^
Association details:
Evidence:
Evidence Level:
Sensitive: C4 – Case Studies
Title:

A Case of Advanced Lung Adenocarcinoma Harboring an Epidermal Growth Factor Receptor(EGFR) Exon 20 Insertion, D770_N771insSVD

Published date:
06/01/2021
Excerpt:
A 57-year-old female was diagnosed as having advanced lung adenocarcinoma...harbored an epidermal growth factor receptor(EGFR)exon 20 insertion, D770_N771insSVD. Afatinib, a second-generation EGFR-tyrosine kinase inhibitor (TKI), was administered as the fourth-line treatment and reduced the size in several lesions.